Regulation of mRNA encoding low density lipoprotein receptor and high density lipoprotein-binding protein in ovine corpora lutea.
Three experiments were conducted to examine the regulation of steady-state concentrations of mRNA encoding ovine low density lipoprotein receptor (LDL-R) and high density lipoprotein-binding protein (HBP) in corpora lutea. In Experiment 1, corpora lutea were collected from ewes on Days 3, 6, 9, 12 and 15 (Day 0, oestrus) of the oestrous cycle. Enriched preparations of small and large steroidogenic luteal cells were also obtained on Days 6, 9, 12 and 15 of the oestrous cycle. In Experiment 2, 16 ewes were hypophysectomized on Day 5 of the oestrous cycle and received saline, luteinizing hormone (LH), growth hormone (GH) or a combination of LH+GH until collection of luteal tissue on Day 12 of the oestrous cycle. Corpora lutea were also collected from pituitary-intact control ewes on Day 5 and Day 12 of the oestrous cycle. In Experiment 3, 13 ewes on Day 11 or Day 12 of the oestrous cycle were administered prostaglandin F2 alpha (PGF2 alpha) and corpora lutea were collected 4 h, 12 h and 24 h later. Corpora lutea were also collected from 4 non-injected and 4 saline-injected (at 24 h) ewes. Results demonstrated that concentrations of mRNA encoding LDL-R did not differ throughout the oestrous cycle. Luteal tissue collected on Day 3 of the oestrous cycle had higher concentrations of mRNA encoding HBP than luteal tissue collected on any other day of the oestrous cycle. Hypophysectomy increased concentrations of mRNA encoding LDL-R but had no effect on concentrations of mRNA encoding HBP. Twelve hours following PGF2 alpha injection concentrations of mRNA encoding LDL-R were decreased but concentrations of mRNA encoding HBP were increased. Concentrations of both LDL-R and HBP mRNA were decreased 24 h following injection of PGF2 alpha. Thus, long-term positive and acute negative regulation of progesterone secretion from the corpus luteum by luteotrophic and luteolytic hormones was not mediated by changes in steady-state concentrations of mRNA encoding LDL-R or HBP.
Tandeski
T R
TR
Department of Physiology, Colorado State University, Fort Collins 80523-1683, USA.
Juengel
J L
JL
Nett
T M
TM
Niswender
G D
GD
D000818:Animals; D002352:Carrier Proteins; D003338:Corpus Luteum / Q000378:metabolism*; D018076:DNA, Complementary / Q000737:chemistry; D015237:Dinoprost / Q000494:pharmacology; D004971:Estrus; D005260:Female; D005786:Gene Expression Regulation; D013006:Growth Hormone / Q000494:pharmacology; D007016:Hypophysectomy; D008075:Lipoproteins, HDL; D007986:Luteinizing Hormone / Q000494:pharmacology; D008565:Membrane Proteins / Q000235:genetics*; D011374:Progesterone / Q000097:blood; D012333:RNA, Messenger / Q000378:metabolism*; D016601:RNA-Binding Proteins; D011973:Receptors, LDL / Q000235:genetics*; D018110:Receptors, Lipoprotein / Q000235:genetics*; D017385:Sequence Homology; D012756:Sheep
D002352:Carrier Proteins; D018076:DNA, Complementary; D008075:Lipoproteins, HDL; D008565:Membrane Proteins; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D011973:Receptors, LDL; D018110:Receptors, Lipoprotein; C031616:high density lipoprotein receptors; C075197:high density lipoprotein binding protein; D011374:Progesterone; D007986:Luteinizing Hormone; D013006:Growth Hormone; D015237:Dinoprost